Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adams’ Suit Could Delay ANDA For URL/Mutual’s Mucinex Generic

This article was originally published in The Tan Sheet

Executive Summary

A lawsuit filed by Adams Respiratory Therapeutics could bring a stay of up to 30 months on FDA's approval of Mutual Pharmaceuticals and United Research Laboratories' application for a generic version of Adams' Mucinex extended-release expectorant product
Advertisement

Related Content

Adams Reinforces Mucinex Patents In Settlement Agreement With Mutual
Adams Reinforces Mucinex Patents In Settlement Agreement With Mutual
Adams Reinforces Mucinex Patents In Settlement Agreement With Mutual
FTC Clarification Of Law On Citizen Petitions Could Bring Antitrust Scrutiny
FTC Clarification Of Law On Citizen Petitions Could Bring Antitrust Scrutiny
FTC Clarification Of Law On Citizen Petitions Could Bring Antitrust Scrutiny
Adams To File Citizen Petition In Move To Block Generic Mucinex
Adams To File Citizen Petition In Move To Block Generic Mucinex
Rx Extended-Release Guaifenesin Must Exit Market By November, FDA Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS099814

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel